miRagen Therapeutics Announces New Interim Data From Phase 1 Clinical Trial of Cobomarsen in Mycosis Fungoides Pharmaceutical Investing
Corcept Therapeutics Announces First Quarter 2018 Financial results and Provides Corporate Update Pharmaceutical Investing
Opiant Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results and Provides Corporate Update Pharmaceutical Investing
INSYS Therapeutics Announces Exclusive License Partnership with Lunatus to Commercialize SUBSYS® (fentanyl sublingual spray) in the Middle East Pharmaceutical Investing
Xenon Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update Pharmaceutical Investing
Cardiol Therapeutics Appoints Dr. James Young as Chair of the Company’s Scientific Advisory Board Cannabis Investing News
Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease Pharmaceutical Investing
Allena Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update Biotech Investing
Zynerba Pharmaceuticals Reports First Quarter 2018 Financial Results and Operational Highlights Pharmaceutical Investing
XOMA Announces $20 Million Credit Facility with Silicon Valley Bank to Advance Royalty-Aggregator Business Model Biotech Investing
